RecruitingNot ApplicableNCT05880407

Pilot Study of Percutaneous Correction of Hallux Valgus

Pilot Study of Percutaneous Correction of Hallux Valgus: Clinical-functional Evaluation of Outcome Randomized Study

Sponsor

Istituto Ortopedico Rizzoli

Enrollment

40 participants

Start Date

Feb 22, 2022

Study Type

INTERVENTIONAL

Conditions

This is a pilot study with a randomized controlled design.

Min Age: 18 YearsMax Age: 65 Years

Patients of both sexes with adult hallux valgus with indication for corrective surgical treatment
HVA (hallux valgus angle): 20°-40°
IMA (intermetatarsal angle): 10°-20°

Patients with instability of the first metatarsophalangeal joint
Patients with severe morphostructural alterations or other pathologies in the foot and lower limb
patients requiring additional surgical procedures
patients with severe vascular and neurological systemic pathologies
systemic pathologies that may impair bone consolidation

Interested in this trial?

Get notified about updates and connect with the research team.

PROCEDURESERI osteotomy

Correction of varus deformity of the 1st Metatarsal that is stabilized with Kirschnner wire

PROCEDUREpercutaneous osteotomy according to Chevron

Correction of varus deformity by osteotomy stabilization with 2 screws inserted via dorsal percutaneous accesses to the 1st Metatarsal.

Istituto Ortopedico Rizzoli

Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT05880407